Mesabi Trust (MSB) 8.97 $MSB Mesoblast's Full 24-Month

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 8:21 PM

Mesabi Trust (MSB) 8.97 $MSB

Mesoblast's Full 24-Month Trial Results for Chronic Low Back Pain Presented at Spine Intervention Society Annual Meeting, Receive Award for Best Basic Science
GlobeNewswire - Mon Aug 01, 5:00AM CDT
Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that the 24-month results from the 100-patient, four-arm, randomized, placebo-controlled Phase 2 trial of its chronic low back pain (CLBP) product candidate MPC-06-ID were presented at the 24 Annual Scientific Meeting of the Spine Intervention Society (SIS) held in New Orleans July 27-30, and received the 2016 Best Basic Science Abstract award at the meeting.
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Synchrony Financial, Wells Fargo and Navistar slip
AP - Tue Jun 14, 3:18PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
MESO: 4.16 (-0.03), MPAA: 26.71 (-1.53), NAV: 11.94 (-0.78), RVNC: 12.82 (-0.43), WFC: 47.70 (-0.11), SYF: 27.35 (-0.56), MSB: 8.97 (-0.43)

Mesabi Trust Has Returned 103.7% Since SmarTrend Recommendation (MSB)
Comtex SmarTrend(R) - Fri May 13, 12:10AM CDT
SmarTrend identified an Uptrend for Mesabi Trust (NYSE:MSB) on January 29th, 2016 at $4.30. In approximately 3 months, Mesabi Trust has returned 103.72% as of today's recent price of $8.76.
MSB: 8.97 (-0.43)

Mesoblast Reports Financial Results for Period Ended 31 March 2016 and Provides Corporate Update
GlobeNewswire - Mon May 09, 6:04PM CDT
Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today reported its consolidated financial results and operational highlights for the third quarter and nine months ended 31 March 2016.
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Mesoblast to Host Third Quarter and Nine Months Financial Results Conference Call and Webcast
GlobeNewswire - Fri May 06, 7:53AM CDT
Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced it will report financial results for the third quarter/nine months ended March 31 2016 and provide a corporate update beginning at 7:00 pm Eastern Time on Monday, May 9 2016 and 9:00 am Australian Eastern Standard Time on Tuesday, May 10 2016.
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Uptrend Call Working As Mesabi Trust Stock Rises 99.3% (MSB)
Comtex SmarTrend(R) - Thu May 05, 12:38PM CDT
SmarTrend identified an Uptrend for Mesabi Trust (NYSE:MSB) on January 29th, 2016 at $4.30. In approximately 3 months, Mesabi Trust has returned 99.30% as of today's recent price of $8.57.
MSB: 8.97 (-0.43)

100.2% Return Seen to Date on SmarTrend Mesabi Trust Call (MSB)
Comtex SmarTrend(R) - Wed Apr 20, 12:15AM CDT
SmarTrend identified an Uptrend for Mesabi Trust (NYSE:MSB) on January 29th, 2016 at $4.30. In approximately 3 months, Mesabi Trust has returned 100.23% as of today's recent price of $8.61.
MSB: 8.97 (-0.43)

Mesabi Trust Press Release
BusinessWire - Fri Apr 15, 3:15PM CDT
The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of twenty cents ($0.20) per Unit of Beneficial Interest payable on May 20, 2016 to Mesabi Trust Unitholders of record at the close of business on April 30, 2016. This compares to no distribution for the same period last year.
MSB: 8.97 (-0.43)

Mesabi Trust Has Returned 33.0% Since SmarTrend Recommendation (MSB)
Comtex SmarTrend(R) - Tue Apr 05, 1:38AM CDT
SmarTrend identified an Uptrend for Mesabi Trust (NYSE:MSB) on January 29th, 2016 at $4.30. In approximately 2 months, Mesabi Trust has returned 33.02% as of today's recent price of $5.72.
MSB: 8.97 (-0.43)

Key United States Patent Granted for Cell-Based Treatment of Rheumatoid Arthritis and Other Rheumatic Conditions
GlobeNewswire - Thu Mar 24, 7:15AM CDT
Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the United States Patent and Trademark Office has granted a key patent covering the use of the Company's proprietary Mesenchymal Precursor Cells (MPCs) for the treatment or prevention of a broad range of rheumatic conditions, including rheumatoid arthritis.
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Phase 3 Heart Failure Trial Size to be Substantially Reduced Following FDA Discussions
GlobeNewswire - Mon Jan 11, 7:00AM CST
Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that the size of the ongoing Phase 3 trial in chronic heart failure (CHF) of its proprietary cell-based medicine MPC-150-IM is planned to be substantially reduced. This follows communications last month between Mesoblast's development and commercial partner, Teva Pharmaceutical Industries Ltd., and the United States Food and Drug Administration (FDA).
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Mesoblast to Present at the 34th Annual J. P. Morgan Healthcare Conference
GlobeNewswire - Thu Jan 07, 4:56PM CST
Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that it will present at the 34th Annual J. P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 13, 2016, at 3.30 p.m. PST/10.30am Thursday, January 14, 2016 (AEDT).
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Downtrend Call Working As Mesabi Trust Stock Falls 53.6% (MSB)
Comtex SmarTrend(R) - Wed Dec 23, 3:58PM CST
SmarTrend identified a Downtrend for Mesabi Trust (NYSE:MSB) on October 16th, 2015 at $10.98. In approximately 2 months, Mesabi Trust has returned 53.55% as of today's recent price of $5.10.
MSB: 8.97 (-0.43)

BUYINS.NET: SNN, CNQ, MSB, MRLN, MET, SPR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Dec 17, 5:56AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of San Anton Resource Corp Inc (NYSE:SNN), Canadian Natural Resources Ltd (NYSE:CNQ), Mesabi Trust (NYSE:MSB), Marlin Business Services Corp (NASDAQ:MRLN), Metalore Resources Ltd (NYSE:MET), SPIRIT AEROSYSTEMS HOLDINGS, INC. (NYSE:SPR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
SNN: 33.48 (+0.30), MRLN: 18.39 (-0.26), MET: 42.21 (-0.34), CNQ: 29.60 (+0.52), SPR: 42.96 (-0.49), MSB: 8.97 (-0.43)

Mesoblast Provides Strategic Update and Reports on First Quarter Financial Results
GlobeNewswire - Wed Dec 16, 3:57PM CST
Materially Strengthened Cash Reserves
MESO: 4.16 (-0.03), MSB: 8.97 (-0.43)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Kailas Campaign Binds Climbers with Gear, Trust

Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...

Arrvel's Thermal Printers: Aiming at E-Com Sellers

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

Amap, Sands China Unleash Tutu Robots for Resort Duty

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

AI Revenue Missteps Shake Semiconductor Stocks

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

KAPSARC Drives Energy Dialogue at WPC in Riyadh

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...